Please login to the form below

Not currently logged in
Email:
Password:

Glenmark Pharmaceuticals

This page shows the latest Glenmark Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Indian court blocks generic of Merck's Januvia

Indian court blocks generic of Merck's Januvia

India's Supreme Court has prevented Glenmark Pharmaceuticals from making and selling a generic of Merck &Co's diabetes blockbuster Januvia. ... Glenmark was ordered to pay part of Merck's legal fees but was excused compensation.

Latest news

  • Merck wins injunction against Januvia generics in India Merck wins injunction against Januvia generics in India

    A case against another drugmaker that has already launched generic copies of the two drugs - Glenmark Pharmaceuticals - is not due to come to court until next month. ... why the courts have blocked Aprica's products whilst letting Glenmark's remain on

  • Merck & Co fails to block generic Januvia in India Merck & Co fails to block generic Januvia in India

    Merck &Co fails to block generic Januvia in India. Court says Glenmark can sell cheap copy of diabetes drug. ... Last week saw yet another setback for multinational pharma companies in India, as Merck &Co failed in a bid to block Glenmark Pharmaceuticals

  • Merck & Co’s asthma drug Singulair faces US generic onslaught

    The FDA licensed generic motelukast tablets from Apotex, Aurobindo Pharma, Endo Pharmaceuticals, Glenmark Generics, Kudco Ireland, Mylan, Roxane Laboratories, Sandoz, Teva Pharmaceuticals and Torrent Pharmaceuticals.

  • Lilly's Strattera patent upheld in US

    Companies looking to capitalise on the loss of patent with their own versions of atomoxetine included Sun Pharmaceutical, Novartis' Sandoz unit, Aurobindo Pharma and Glenmark Pharmaceuticals.

  • Glenmark to launch anti-diarrhoea drug

    Glenmark to launch anti-diarrhoea drug. Glenmark Pharmaceuticals is preparing to launch novel anti-diarrhoea drug Crofelemer following successful phase III trials. ... Glenmark Pharmaceuticals has announced it is preparing to launch novel anti-diarrhoea

More from news
Approximately 3 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics